p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations
- 1 February 1999
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 187 (3), 302-307
- https://doi.org/10.1002/(sici)1096-9896(199902)187:3<302::aid-path243>3.0.co;2-u
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Cancer Cell CyclesScience, 1996
- Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinomaBritish Journal of Cancer, 1996
- p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survivalBritish Journal of Cancer, 1996
- Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoDScience, 1995
- Cell Cycle Control and CancerScience, 1994
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994
- Cloning of Senescent Cell-Derived Inhibitors of DNA Synthesis Using an Expression ScreenExperimental Cell Research, 1994
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993